AVERT – Apixaban to Prevent Cancer VTE
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer. Carrier M, Abou-Nassar K, Mallick R, et al.; AVERT Investigators. N
Continue readingCategory: Heme/Onc
SOME – Screening for Cancer After Unprovoked VTE
Screening for Occult Cancer in Unprovoked Venous Thromboembolism. Carrier M, Lazo-Langner A, Shivakumar S, et al; SOME Investigators. N Engl
Continue readingRATIFY – Midostaurin for AML
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation. Stone RM, Mandrekar SJ, Sanford BL, et al. N
Continue readingCheckMate-003 – Nivolumab Phase 1 Safety
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. Topalian SL, Hodi FS, Brahmer JR, et al. N Engl
Continue readingCARAVAGGIO – Apixaban for Cancer VTE
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer. Agnelli G, Becattini C, Meyer G, et al.; for the
Continue readingCombination Therapy for AML
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia. DiNardo CD, Jonas BA, Pullarkat V, Tet al. N Engl J
Continue readingTransfusion in Upper GI Bleeding
“Transfusion Strategies for Acute Upper Gastrointestinal Bleeding” N Engl J Med. 2013 Jan 3;368(1):11-21. [Full text] Summary by Gordon Pelegrin
Continue readingATRA–Arsenic trioxide for APL
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia Lo-Coco F, Avvisati G, Vignetti M, et al.; Gruppo Italiano Malattie
Continue readingTRISS
“Lower versus Higher Hemoglobin Threshold for Transfusion in Septic Shock“ Holst LB, Haase N, Wetterslev J, et al.; TRISS Trial
Continue readingCLOT
“Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer” by the Randomized Comparison
Continue reading